The effects of clozapine on the GSK‐3‐mediated signaling pathway

Authors:
  • MSMyoung Suk Seo
    Myoung Suk Seo
  • MRMyoung-Sun Roh
    Myoung-Sun Roh
  • YKYeni Kim
    Yeni Kim
  • SYSe Chang Yoon
    Se Chang Yoon
  • YKYong Sik Kim
    Yong Sik Kim

Abstract
We investigated the effect of 10 μM clozapine on the activity of glycogen synthase kinase‐3β (GSK‐3β) and its upstream and downstream molecules in SH‐SY5Y human neuroblastoma cells. Clozapine activates both Akt‐ and Dvl‐mediated phosphorylation of GSK‐3β through phosphorylation at Ser9, and increased total cellular and intranuclear levels of β‐catenin. Pretreatment with the specific inhibitor of the phosphatidylinositol 3‐kinase (PI3K)‐Akt pathway, LY294002 (20 μM), prevented the phosphorylation of Akt but did not affect the phosphorylation of GSK‐3β. These results suggest that clozapine regulates the phosphorylation of GSK‐3β through Wnt signal pathways involving Dvl upstream but not through the PI3K‐Akt pathway in SH‐SY5Y cells.

This publication has 19 references indexed in Scilit: